Press release Communiqué de presse

Share the news     Partagez les nouvelles

Email Facebook LinkedIn Twitter

Press release Communiqué de presse

February 20, 2004 20 February, 2004

Pheromone Sciences Corp Announces CFO Change

Toronto, Ontario -- February 20, 2004 -- Pheromone Sciences Corp. (TSX-V:PHS) today announced that it has accepted the resignation of Mr. Larry Cooper from his position of Chief Financial Officer of the company to pursue other interests effective February 20, 2004.

Mr. Florian Meyer MBA, CA has assumed the role of Chief Financial Officer effective today.

This transition is not expected to adversely affect the function of the company.

Pheromone Sciences Corp. is a biotechnology and medical diagnostics device research and development company that focuses on commercializing technologies in the field of human and animal reproduction.

Statements contained in this press release, including those pertaining to scientific and clinical research, commercialization plans, strategic alliances, and intellectual property protection, other than statements of historical fact, are forward-looking statements subject to a number of uncertainties that could cause actual results to differ materially from statements made. The TSX Ventures Exchange has not reviewed and does not accept responsibility for the adequacy or the contents of this news release.